Vanderbilt Univeristy SC is a clinical research site located in Nashville, Tennessee, United States 37232.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Vanderbilt Univeristy SC has participated in 1 clinical trials.
Therapeutic areas: Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt Univeristy SC has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt Univeristy SC has 1 clinical trials on record. Their work covers Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer.
Vanderbilt Univeristy SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.